Doxorubicin HCl Loaded Liposomes(Lipo-019RG)
| Product Summary | |
|---|---|
| Name | Doxorubicin HCl Loaded Liposomes |
Download Datasheet
|
|
| Cat No. | Lipo-019RG |
| Product Overview | Doxorubicin (Adriamycin, NSC 123127, DOX, Hydroxydaunorubicin) HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage, mitophagy and apoptosis in tumor cells. Doxorubicin reduces basal phosphorylation of AMPK. Doxorubicin is used in the concomitant treatment of HIV-infected patients but is found to be at high risk of HBV reactivation. This product is a PEG modified pre-formulated liposome with Doxorubicin loaded. It is supplied ready to use in vitro or in vivo studies. The lipid composition is HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol). |
| Lipid Composition | HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) |
| Active Ingredients | Doxorubicin HCl |
| Form | Liquid |
| Storage Buffer | PBS, pH 7.4 |
| Concentration | 2 mg/mL (Concentration Doxorubicin); Lipid Concentration 30 mM |
| Stability | 6 months |
| Storage | 2 °C to 8 °C (do not freeze) |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
Can you provide information on the size and composition of your liposomes?
Yes, we offer detailed specifications for each product, enabling researchers to select liposomes that best match their experimental requirements.
-
Do you offer customization options for liposome formulations?
Yes, we offer customization services to meet the unique demands of research projects. Our team of experts can work with customers to develop custom liposome formulations tailored to their specific needs, ensuring optimal results for their experiments.
-
What analytical and characterization data do you provide with your liposome products?
We provide comprehensive analytical and characterization data for all our liposome products, such as size distribution, zeta potential, and encapsulation efficiency.
